Frances A. Shepherd
0000-0002-3610-3533
Publication & Citation Trends
Publications
0 total
Assessing the feasibility and external validity of natural language processing-extracted data for advanced lung cancer patients.
Cited by 1
Semantic Scholar
Weight, BSA, Toxicity, and Efficacy of Tyrosine Kinase Inhibitors for ALK-Mutated NSCLC
Cited by 1
Semantic Scholar
Prognostic and predictive effects of TP53 co-mutation in patients with non-small cell lung cancer with rare treatable driver mutations.
Cited by 2
Semantic Scholar
Real-World Creatinine-Based Estimates of Acute and Chronic Kidney Dysfunction in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Receiving Tyrosine Kinase Inhibitors.
Cited by 1
Semantic Scholar
Treatment patterns and outcomes in KRASG12C-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study.
Cited by 8
Semantic Scholar
Discover: Plasma testing in patients with advanced undergenotyped NSCLC and in targeted therapy resistance
Cited by 0
Semantic Scholar
PP01.10 Real-World Outcomes of Patients with Advanced EGFR-Mutated NSCLC in Canada Using AI-Extracted Data
Cited by 0
Semantic Scholar
Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors OA
Cited by 2
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(728)
Lung Cancer Research Studies
(325)
Lung Cancer Diagnosis and Treatment
(266)
Cancer Genomics and Diagnostics
(157)
Colorectal Cancer Treatments and Studies
(129)
Affiliations
Université Paris-Sud
Ontario Institute for Cancer Research
University of Southern California
National Health Service
Western University